#RCTs

Noah Haber

NoahHaber

Alright fellow epi and econ friends, gather 'round, time for me to talk about this articleBecause I am a native econ whose life quest it is to bridge the epi/econ

Caio de Assis Moura Tavares

caiodeamtavares

1/11The Lancet just published the SENIOR-NSTEMI trial (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30930-2/fulltext) with very interesting findings: 2/11Prospective observational data from 5 collaborating Hospitals in

Ioana A. Cristea

IoanaA_Cristea

I am sorry but this @WIRED article is a pretty sloppy caricature of John Ioannidis. @dhfreedman (whose @TheAtlantic article is how I told my parents who I was going to

Subhasree Ray

DrSubhasree

Tomato:One of the most basic vegetables (originally a fruit) in Indian cuisine is a powerhouse of nutrients - Vitamin K1, B9, C, potassium, antioxidants - lycopene, beta-carotene, naringenin & chlorogenic

Payton J. Jones

paytonjjones

The field of clinical psychology naturally provides a perfect little petri dish for pseudoscience. Why?1) Common factors do the heavy lifting in psychotherapy, meaning almost any type of therapy will

Sharath Rajagopalan

ShaRajagopalan

Simply amazing to see the clinical and the QoL improvements noted with #Digoxin in the RATE-AF trial presented at #ESCCongress2020. Among medicine residents, I would attribute less use of digoxin

Ed

Rx_Ed

What is Remdesivir?This is a thread on the pharmacology of the drug & its hypothesized mechanism of action against #coronavirus #COVID19. I’ll also mention some of the anticipated side effects/toxicity,

Jonathan Shedler

JonathanShedler

1/ More than a few psychologists have asked just what is meant by "evidence-based practice" and "evidence based therapy." This thread is a response I gave to someone who asked

Prof Darrel Francis ☺ Mk CardioFellows Great Again

ProfDFrancis

Happy Easter Sunday!Today's tweetorial is short and nasty, like me.#FOAMED #MEDED #CardiotwitterLast night I broke into a pharmacy to steal some drugs. After crowbar'ing my way in, I was in

Brad Shapiro

btshapir

And now, as promised, a thread on my new *working* paper (feedback welcome): “Promoting Wellness or Waste? Evidence from Antidepressant Advertising” (link) 1/22https://papers.ssrn.com/abstract=3130327 DTCA is controversial. Opposition h

Joanna Poole 💙

Jopo_dr

In my opinion it is exactly ARDS. It fits the criteria and would be included in trials. Indeed, having meta-analysed pressures and tidal volumes in several RCTS of ARDS in

Nick Mark MD

nickmmark

Interesting preprint of the #LIVEAIR study of #lenzilumab in #COVID19:-double blind RCT n=502 hospitalized pts on suppl O2-lenzilumab associated with improved survival w/o ventilation: 84% vs 77.9% -larger benefit when

Jennifer Doleac

jenniferdoleac

As a researcher, I now take as given that unnecessary escalation of incidents (e.g. to arrests/violence), as well as racial bias, are both (related) problems in policing. The question is

Rahul Ganatra

rbganatra

1/Should we use #hydroxychloroquine (HCQ) +/- azithromycin to treat #COVID19 #SARSCoV2? Let’s take a look at the data.Here’s: #HowIReadThisPaper on the only trial published to date on HCQ for COVID19

Gus Hamilton

gushamilton

New (short) paper out - A Bayesian re-analysis of the convalescent plasma (CP) arm of RECOVERY with @DrToddLee @karlahemming @rjlilford and @DavidT_Arnold. Key question: Is CP futile in hospitalised patients

Health Nerd

GidMK

This is one of the larger trials of hydroxychloroquine, ivermectin, povidone-iodine and zinc for prevention of COVID-19At first, it appears positive, but there are some worrying issuesSome peer-review on twitter